EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment of tentative epidemiological cutoff values of faropenem against Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pneumoniae

Shi Wu, Yang Yang, Dandan Yin, Feng Xue, Yun Li, Wei Kang, Qiwen Yang, Jie Lin, Yunsong Yu, Demei Zhu, Yan Guo, Fupin Hu

Frontiers in Cellular and Infection Microbiology · 22.04.2026 · 16

DOI: 10.3389/fcimb.2026.1757254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 22.04.2026. Verfasst von Shi Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai, China. Hauptthemen laut MEDLINE: Staphylococcus aureus, Haemophilus influenzae, Streptococcus pneumoniae, Escherichia coli. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to establish tentative epidemiological cutoff values (TECOFFs) for faropenem against Escherichia coli , Klebsiella pneumoniae , Staphylococcus aureus , Haemophilus influenzae , and Streptococcus pneumoniae based on minimum inhibitory concentration (MIC) distributions.

Methods

A total of 2,032 bacterial isolates were collected from Peking University First Hospital, Peking Union Medical College Hospital, Huashan Hospital affiliated with Fudan University, and Sir Run Run Shaw Hospital affiliated with Zhejiang University School of Medicine between 2019 and 2021. The susceptibility of these bacteria to faropenem was determined using the broth microdilution and disk diffusion methods in the clinical microbiology laboratories of these four hospitals. To establish wild-type TECOFFs for faropenem, isolates susceptible to ertapenem for E. coli and K. pneumoniae , those susceptible to oxacillin for S. aureus , and those with unscreened susceptibility for H. influenzae and S. pneumoniae were regarded as wild-type strains.

Results

The MIC TECOFF for faropenem against E. coli was determined to be 2 mg/L, with MIC ≤2 mg/L indicating wild-type strains and MIC ≥4 mg/L indicating non-wild-type strains. The corresponding inhibition zone diameter TECOFF for E. coli was 19 mm, where an inhibition zone diameter ≤18 mm indicates non-wild-type strains and ≥19 mm indicates wild-type strains. For K. pneumoniae , the MIC TECOFF was also 2 mg/L, with similar cutoffs established for the inhibition zones. The MIC TECOFF for faropenem against S. aureus was 0.25 mg/L, for H. influenzae was 1 mg/L, and for S. pneumoniae was 2 mg/L. The corresponding inhibition zone diameter ECOFF for faropenem against S. aureus was 31 mm, for H. influenzae was 14 mm, and for S. pneumoniae was 33 mm.

Conclusion

The TECOFFs for faropenem against the tested bacteria were established. These data are useful for clinical microbiologists and clinicians in the interpretation of the results of faropenem susceptibility testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusHaemophilus influenzaeStreptococcus pneumoniaeEscherichia coliAnti-Bacterial AgentsKlebsiella pneumoniaebeta-LactamsMicrobial Sensitivity TestsHumans

Stichwörter der Autor:innen

Escherichia coliHaemophilus influenzaeKlebsiella pneumoniaeStaphylococcus aureusStreptococcus pneumoniaeantimicrobial susceptibility testingepidemiological cut-off valuesfaropenem

Substanzen

Anti-Bacterial Agentsfropenembeta-Lactams

Autor:innen und Institutionen

  • Institute of Antibiotics, Huashan Hospital, Fudan University, and Key Laboratory of Clinical Pharmacology of Antibiotics, Shanghai, China.
  • Department of Laboratory Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.
  • Department of Laboratory Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

Zitieren

APA

Wu, S., Yang, Y., Yin, D., Xue, F., Li, Y., Kang, W., Yang, Q., Lin, J., Yu, Y., Zhu, D., Guo, Y., & Hu, F. (2026). Establishment of tentative epidemiological cutoff values of faropenem against Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pneumoniae. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1757254

Vancouver

Wu S, Yang Y, Yin D, Xue F, Li Y, Kang W, et al. Establishment of tentative epidemiological cutoff values of faropenem against Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pneumoniae. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1757254

BibTeX
@article{Wu2026,
  author = {Wu, Shi and Yang, Yang and Yin, Dandan and Xue, Feng and Li, Yun and Kang, Wei and Yang, Qiwen and Lin, Jie and Yu, Yunsong and Zhu, Demei and Guo, Yan and Hu, Fupin},
  title = {Establishment of tentative epidemiological cutoff values of faropenem against Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pneumoniae},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1757254}
}
Kostenlos starten →